Correlation Between Cardio Diagnostics and Armata Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Armata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Armata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Armata Pharmaceuticals, you can compare the effects of market volatilities on Cardio Diagnostics and Armata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Armata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Armata Pharmaceuticals.

Diversification Opportunities for Cardio Diagnostics and Armata Pharmaceuticals

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cardio and Armata is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Armata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Armata Pharmaceuticals and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Armata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Armata Pharmaceuticals has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Armata Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and Armata Pharmaceuticals

Assuming the 90 days horizon Cardio Diagnostics Holdings is expected to under-perform the Armata Pharmaceuticals. In addition to that, Cardio Diagnostics is 2.3 times more volatile than Armata Pharmaceuticals. It trades about -0.31 of its total potential returns per unit of risk. Armata Pharmaceuticals is currently generating about 0.07 per unit of volatility. If you would invest  198.00  in Armata Pharmaceuticals on October 20, 2024 and sell it today you would earn a total of  8.00  from holding Armata Pharmaceuticals or generate 4.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.0%
ValuesDaily Returns

Cardio Diagnostics Holdings  vs.  Armata Pharmaceuticals

 Performance 
       Timeline  
Cardio Diagnostics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cardio Diagnostics Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Cardio Diagnostics showed solid returns over the last few months and may actually be approaching a breakup point.
Armata Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Armata Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest abnormal performance, the Stock's primary indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Cardio Diagnostics and Armata Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardio Diagnostics and Armata Pharmaceuticals

The main advantage of trading using opposite Cardio Diagnostics and Armata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Armata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will offset losses from the drop in Armata Pharmaceuticals' long position.
The idea behind Cardio Diagnostics Holdings and Armata Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities